Pathogen proteomes during infection: A basis for infection research and novel control strategies

Journal of Proteomics

Volumn 73, Issue 11, 2010, Pages 2267-2276

  Bumann, Dirk ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Bacterial infection; Pathogen metabolism; Vaccine antigen identification

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; CELL CULTURE; CONTROL STRATEGY; DISEASE CONTROL; ENZYME METABOLISM; HOST PATHOGEN INTERACTION; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SALMONELLOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS; PROTEOME; PROTEOMICS; RESEARCH; SALMONELLA; SALMONELLA INFECTIONS; VACCINATION;

BACTERIA (MICROORGANISMS); SALMONELLA;

EID: 77957234670     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.08.004     Document Type: Review

References (67)

1. Norrby S.R., Nord C.E., Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005, 5:115-119.
2. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
3. Arias, C.A., Contreras, G.A. and Murray, B.E. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 16, 555-62.
4. Nannini E., Murray B.E., Arias C.A. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 2010, 30.
5. Boucher H.W., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
6. Molestina R.E., Klein J.B., Miller R.D., Pierce W.H., Ramirez J.A., Summersgill J.T. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 2002, 70:2976-2981.
7. Mattow J., et al. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 2006, 6:2485-2494.
8. Shi L., et al. Proteomic analysis of Salmonella enterica serovar typhimurium isolated from RAW 264.7 macrophages: identification of a novel protein that contributes to the replication of serovar typhimurium inside macrophages. J Biol Chem 2006, 281:29131-29140.
9. Xia Q., Wang T., Taub F., Park Y., Capestany C.A., Lamont R.J., et al. Quantitative proteomics of intracellular Porphyromonas gingivalis. Proteomics 2007, 7:4323-4337.
10. Schmidt, F. et al. Time-resolved quantitative proteome profiling of host-pathogen interactions: the response of Staphylococcus aureus RN1HG to internalisation by human airway epithelial cells. Proteomics 10, 2801-11.
11. Lasonder E., et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 2002, 419:537-542.
12. Florens L., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
13. Hall N., et al. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 2005, 307:82-86.
14. Khan S.M., Franke-Fayard B., Mair G.R., Lasonder E., Janse C.J., Mann M., et al. Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology. Cell 2005, 121:675-687.
15. Lasonder E., et al. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog 2008, 4:e1000195.
16. Paape D., et al. Transgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes. Mol Cell Proteomics 2008, 7:1688-1701.
17. Paape D., Barrios-Llerena M.E., Le Bihan T., Mackay L., Aebischer T. Gel free analysis of the proteome of intracellular Leishmania mexicana. Mol Biochem Parasitol 2009, 169:108-114.
18. Nesvizhskii A.I., Aebersold R. Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics 2005, 4:1419-1440.
19. Rabilloud, T. (2010). Two-dimensional gel electrophoresis in proteomics: past, present and future. 73 (11): 2064-2077.
20. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 2000, 97:9390-9395.
21. Sheppard M., Webb C., Heath F., Mallows V., Emilianus R., Maskell D., et al. Dynamics of bacterial growth and distribution within the liver during Salmonella infection. Cell Microbiol 2003, 5:593-600.
22. Boyce J.D., Cullen P.A., Nguyen V., Wilkie I., Adler B. Analysis of the Pasteurella multocida outer membrane sub-proteome and its response to the in vivo environment of the natural host. Proteomics 2006, 6:870-880.
23. Twine S.M., Mykytczuk N.C., Petit M.D., Shen H., Sjostedt A., Wayne Conlan J., et al. In vivo proteomic analysis of the intracellular bacterial pathogen, Francisella tularensis, isolated from mouse spleen. Biochem Biophys Res Commun 2006, 345:1621-1633.
24. Becker D., Selbach M., Rollenhagen C., Ballmaier M., Meyer T.F., Mann M., et al. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 2006, 440:303-307.
25. Tarun A.S., et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 2008, 105:305-310.
26. Wendland M., Bumann D. Optimization of GFP levels for analyzing Salmonella gene expression during an infection. FEBS Lett 2002, 521:105-108.
27. Bumann D. Examination of Salmonella gene expression in an infected mammalian host using the green fluorescent protein and two-colour flow cytometry. Mol Microbiol 2002, 43:1269-1283.
28. Wang Q., et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 2010, 327:1004-1007.
29. Macek B., Gnad F., Soufi B., Kumar C., Olsen J.V., Mijakovic I., et al. Phosphoproteome analysis of E. coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation. Mol Cell Proteomics 2008, 7:299-307.
30. Rollenhagen C., Bumann D. Salmonella enterica highly expressed genes are disease specific. Infect Immun 2006, 74:1649-1660.
31. Malmstrom J., Beck M., Schmidt A., Lange V., Deutsch E.W., Aebersold R. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature 2009, 460:762-765.
32. Mazurkiewicz P., Tang C.M., Boone C., Holden D.W. Signature-tagged mutagenesis: barcoding mutants for genome-wide screens. Nat Rev Genet 2006, 7:929-939.
33. Haraga A., Ohlson M.B., Miller S.I. Salmonellae interplay with host cells. Nat Rev Microbiol 2008, 6:53-66.
34. Majowicz, S.E. et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50, 882-9.
35. Bhan M.K., Bahl R., Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005, 366:749-762.
36. Alcaine S.D., Warnick L.D., Wiedmann M. Antimicrobial resistance in nontyphoidal Salmonella. J Food Prot 2007, 70:780-790.
37. Kariuki, S. et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 48, 2171-6.
38. Ahmed D., D'Costa L.T., Alam K., Nair G.B., Hossain M.A. Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh. Antimicrob Agents Chemother 2006, 50:3516-3517.
39. Santiviago C.A., Reynolds M.M., Porwollik S., Choi S.H., Long F., Andrews-Polymenis H.L., et al. Analysis of pools of targeted Salmonella deletion mutants identifies novel genes affecting fitness during competitive infection in mice. PLoS Pathog 2009, 5:e1000477.
40. Chaudhuri R.R., et al. Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice. PLoS Pathog 2009, 5:e1000529.
41. Akashi H., Gojobori T. Metabolic efficiency and amino acid composition in the proteomes of Escherichia coli and Bacillus subtilis. Proc Natl Acad Sci USA 2002, 99:3695-3700.
42. Bowe F., Lipps C.J., Tsolis R.M., Groisman E., Heffron F., Kusters J.G. At least four percent of the Salmonella typhimurium genome is required for fatal infection of mice. Infect Immun 1998, 66:3372-3377.
43. Thöne F., Schwanhäuser B., Becker D., Ballmaier M., Bumann D. FACS-isolation of Salmonella-infected cells with defined bacterial load from mouse spleen. J Microbiol Meth 2007, epub ahead of print Sep 11.
44. Wang, P.I. and Marcotte, E.M. (2010). It's the machine that matters: predicting gene function and phenotype from protein networks. 73 (11): 2277-2289.
45. Keseler I.M., et al. EcoCyc: a comprehensive view of Escherichia coli biology. Nucleic Acids Res 2009, 37:D464-D470.
46. Kanehisa M., et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-D484.
47. Bumann D. System-level analysis of Salmonella metabolism during infection. Curr Opin Microbiol 2009, 12:559-567.
48. Brinster S., Lamberet G., Staels B., Trieu-Cuot P., Gruss A., Poyart C. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 2009, 458:83-86.
49. Balemans, W., Lounis, N., Gilissen, R., Guillemont, J., Simmen, K., Andries, K. and Koul, A. Essentiality of FASII pathway for Staphylococcus aureus. Nature 463, E3; discussion E4.
50. Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A. and Poyart, C. Brinster et al. reply. Nature 463, E4-E4.
51. Gama-Castro S., et al. RegulonDB (version 6.0): gene regulation model of Escherichia coli K-12 beyond transcription, active (experimental) annotated promoters and Textpresso navigation. Nucleic Acids Res 2008, 36:D120-D124.
52. Yoon H., McDermott J.E., Porwollik S., McClelland M., Heffron F. Coordinated regulation of virulence during systemic infection of Salmonella enterica serovar Typhimurium. PLoS Pathog 2009, 5:e1000306.
53. Webb C., Moreno M., Wilmes-Riesenberg M., Curtiss R., Foster J.W. Effects of DksA and ClpP protease on sigma S production and virulence in Salmonella typhimurium. Mol Microbiol 1999, 34:112-123.
54. Yamamoto T., et al. Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha. Infect Immun 2001, 69:3164-3174.
55. Bambini S., Rappuoli R. The use of genomics in microbial vaccine development. Drug Discov Today 2009, 14:252-260.
56. Toomey D., Hoppe H.C., Brennan M.P., Nolan K.B., Chubb A.J. Genomes2Drugs: identifies target proteins and lead drugs from proteome data. PLoS ONE 2009, 4:e6195.
57. Rollenhagen C., Sorensen M., Rizos K., Hurvitz R., Bumann D. Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proc Natl Acad Sci USA 2004, 101:8739-8744.
58. Sabarth N., Hurwitz R., Meyer T.F., Bumann D. Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy. Infect Immun 2002, 70:6499-6503.
59. Harris Jb Fau - Baresch-Bernal, A. et al. Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi.
60. Hu Y Fau - Cong, Y., Cong Y Fau - Li, S., Li S Fau - Rao, X., Rao X Fau - Wang, G., Wang G Fau - Hu, F. and Hu, F. Identification of in vivo induced protein antigens of Salmonella enterica serovar Typhi during human infection.
61. Pappalardo F Fau - Halling-Brown, M.D. et al. ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization.
62. Zarling A.L., Polefrone J.M., Evans A.M., Mikesh L.M., Shabanowitz J., Lewis S.T., et al. Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc Natl Acad Sci USA 2006, 103:14889-14894.
63. Depontieu F.R., et al. Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc Natl Acad Sci USA 2009, 106:12073-12078.
64. Kang H.Y., Curtiss R. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol 2003, 37:99-104.
65. Mittrucker H.W., Steinhoff U., Kohler A., Krause M., Lazar D., Mex P., et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci USA 2007, 104:12434-12439.
66. Halling-Brown M Fau - Shaban, R. et al. Proteins accessible to immune surveillance show significant T-cell epitope depletion: implications for vaccine design.
67. Cline M.S., et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007, 2:2366-2382.